electroCore reports record Q2 2023 revenue of ~$3.55M, up 65% YoY

electroCore, Inc.

2023-Q2 EPS reported -$2.27 revenue$6,331,000

Record quarterly revenue of ~$3.55M (preliminary unaudited) for Q2 2023, +65% vs Q2 2022.
Government channel revenue (VA/DoD) grew ~75% to ~$2.085M; 138 facilities now purchasing.
US commercial cash-pay prescribers grew to 2,225 (from 660 a year ago); revenue ~$430K.
Truvaga net revenue ~$291K (vs $147K in Q1 2023); TAC-STIM revenue ~$311K.
Reaffirmed FY 2023 revenue guidance of $14.0-$15.0M; net cash used ~$3.5M in Q2.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

electroCore, Inc. reported the second quarter of 2023 results: revenue approximately $3,550,000.

Period: the second quarter of 2023
Revenue: approximately $3,550,000
Result: preliminary results

Exact text from the filing

The Company anticipates reporting record quarterly revenue of approximately $3,550,000 for the quarter ended June 30, 2023.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

electroCore, Inc. reported the year ending December 31, 2023 results: revenue $14.0-$15.0 million. Guidance reaffirmed.

Period: the year ending December 31, 2023
Revenue: $14.0-$15.0 million
Guidance: reaffirmed
Result: guidance update

Exact text from the filing

The Company reiterated its revenue guidance of $14.0-$15.0 million for the year ending December 31, 2023.

View on SEC.gov

Browse all earnings releases →

electroCore, Inc. filing history →

Source: SEC EDGAR

accession 0001193805-23-000968

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.